More on HRMY
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $35.32 |
|
|||
| Open | $35.63 | ||||
| 52 Wk High | $1.35 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $36.52 | ||||
| Day Low | $35.36 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 623,902 | ||||
- Form 3 Harmony Biosciences Hold For: Jul 16 Filed by: Mollichella Stephen M.
- Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
- H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
- H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
- Form 8-K Harmony Biosciences Hold For: Jul 16
- Harmony Biosciences posts record Q2 revenue, CFO steps down
- Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition
- Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)
- Form 144 Harmony Biosciences Hold Filed by: Kapadia Sandip
- Form 144 Harmony Biosciences Hold Filed by: Kapadia Sandip
Entities mentioned with HRMY
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
